Digoxin description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Digoxin

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

DIGOXIN DESCRIPTION



Digoxin






CLINICAL PHARMACOLOGY

Mechanism of Action


PHARMACOKINETICS






Distribution
DOSAGE AND ADMINISTRATION: Serum Digoxin Concentrations


Metabolism


Excretion


Special Populations

DOSAGE AND ADMINISTRATION


Pharmacodynamic and Clinical Effects




Hemodynamic Effects


Chronic Heart Failure

DOSAGE AND ADMINISTRATION





Chronic Atrial Fibrillation


INDICATIONS & USAGE

Heart Failure


Atrial Fibrillation


DIGOXIN CONTRAINDICATIONS



WARNINGS

Sinus Node Disease and AV Block


Accessory AV Pathway (Wolff-Parkinson-White Syndrome)


Use in Patients with Preserved Left Ventricular Systolic Function


PRECAUTIONS

Use in Patients with Impaired Renal Function
DOSAGE AND ADMINISTRATION

Use in Patients with Electrolyte Disorders



Use in Thyroid Disorders and Hypermetabolic States


Use in Patients with Acute Myocardial Infarction


Use During Electrical Cardioversion


Use in Patients with Myocarditis


Use in Patients with Beri Beri Heart Disease


Laboratory Test Monitoring
DOSAGE AND ADMINISTRATION

DRUG INTERACTIONS

CLINICAL PHARMACOLOGY: Absorption
Due to the considerable variability of these interactions; the dosage of digoxin should be individualized when patients receive these medications concurrently. Furthermore, caution should be exercised when combining digoxin with any drug that may cause a significant deterioration in renal function, since a decline in glomerular filtration or tubular secretion may impair the excretion of digoxin.

DRUG & OR LABORATORY TEST INTERACTIONS



PREGNANCY

Teratogenic Effects: Pregnancy Category C


NURSING MOTHERS



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



GERIATRIC USE

DOSAGE AND ADMINISTRATION

PEDIATRIC USE



DIGOXIN ADVERSE REACTIONS




Adults: Cardiac
WARNINGSPRECAUTIONS

Gastrointestinal


CNS


Other





Infants and Children

www.fda.gov/medwatch

OVERDOSAGE

Signs and Symptoms
ADVERSE REACTIONSDOSAGE AND ADMINISTRATION

Adults
ADVERSE REACTIONS


Children




Treatment
WARNINGSPRECAUTIONS: Drug Interactions

Massive Digitalis Overdosage
Administration of Potassium

Administration of Potassium


Massive Digitalis Overdosage




DOSAGE & ADMINISTRATION

General




PRECAUTIONS

Serum Digoxin Concentrations
Maintenance Dosing





WARNINGSPRECAUTIONS


Heart Failure: Adults




Rapid Digitalization with a Loading Dose
PRECAUTIONS



CLINICAL PHARMACOLOGY

Maintenance Dosing








Example


Infants and Children







Atrial Fibrillation


Dosage Adjustment When Changing Preparations

CLINICAL PHARMACOLOGY: Pharmacokinetics

HOW SUPPLIED







STORAGE AND HANDLING




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Digoxin






Digoxin

Digoxin

Digoxin TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-028(NDC:0527-1324)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
DIGOXIN DIGOXIN 0.125 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
HYPROMELLOSE 2208 (15000 MPA.S)
MAGNESIUM STEARATE
D&C YELLOW NO. 10

Product Characteristics

Color Size Imprint Code Shape
yellow 7 mm JSP;544 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-028-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076268 2011-07-20


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.